Canadian Court Upholds Patent Holder's Compensation Choice

摘要

Only the patent-holding pharmaceutical company can choose how it is compensated for patent infringement, a Canadian court confirmed. The Federal Court of Appeal's ruling unequivocally rejects the argument by generic manufacturer Apotex Inc. that an infringer should have a say in how compensation is determined, intellectual property lawyers told Bloomberg Law.